Variant report

Variant	rs1668549
Chromosome Location	chr15:42411434-42411435
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr15:42398541..42400541-chr15:42411116..42413868,2	K562	blood:
2	chr15:42359873..42362452-chr15:42410836..42413040,2	K562	blood:

Extended variants
information (count: 46 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:37)

rs_ID	r²[population]
rs2122676	0.90[ASN][1000 genomes]
rs2167294	0.90[ASN][1000 genomes]
rs2280248	0.88[CEU][hapmap];0.84[CHB][hapmap]
rs2412669	0.90[ASN][1000 genomes]
rs2677756	0.99[ASN][1000 genomes]
rs28414830	0.90[ASN][1000 genomes]
rs28499088	0.90[ASN][1000 genomes]
rs28665345	0.90[ASN][1000 genomes]
rs28718476	0.90[ASN][1000 genomes]
rs55926717	0.88[ASN][1000 genomes]
rs56040775	0.90[ASN][1000 genomes]
rs58555641	0.81[ASN][1000 genomes]
rs58905750	0.90[ASN][1000 genomes]
rs600957	0.96[ASN][1000 genomes]
rs60179947	0.84[ASN][1000 genomes]
rs60279267	0.90[ASN][1000 genomes]
rs60513852	0.90[ASN][1000 genomes]
rs60759517	0.90[ASN][1000 genomes]
rs60807341	0.89[ASN][1000 genomes]
rs61190589	0.90[ASN][1000 genomes]
rs635548	0.88[CEU][hapmap];0.85[CHB][hapmap]
rs653717	0.86[AMR][1000 genomes];0.97[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs655427	0.84[CEU][hapmap]
rs6650522	0.99[ASN][1000 genomes]
rs675996	0.93[ASN][1000 genomes]
rs694456	0.89[CEU][hapmap]
rs72489213	0.90[ASN][1000 genomes]
rs74011727	0.90[ASN][1000 genomes]
rs74011729	0.90[ASN][1000 genomes]
rs74011732	0.88[ASN][1000 genomes]
rs776716	0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs776718	0.80[ASN][1000 genomes]
rs8023346	0.90[ASN][1000 genomes]
rs8030796	0.90[ASN][1000 genomes]
rs8032387	0.90[ASN][1000 genomes]
rs8042280	0.90[ASN][1000 genomes]
rs9672757	0.87[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:9 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv931223	chr15:41989960-42781757	Enhancers Weak transcription Strong transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	81 gene(s)	inside rSNPs	diseases
2	nsv1035998	chr15:42098896-42434254	Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA	38 gene(s)	inside rSNPs	diseases
3	nsv529687	chr15:42157320-42621682	Weak transcription Strong transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	59 gene(s)	inside rSNPs	diseases
4	nsv1049445	chr15:42239738-42830484	Enhancers Strong transcription Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	73 gene(s)	inside rSNPs	diseases
5	nsv542366	chr15:42239738-42830484	Weak transcription Active TSS Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	73 gene(s)	inside rSNPs	diseases
6	nsv471683	chr15:42334375-42502982	Enhancers Bivalent Enhancer Genic enhancers Strong transcription Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
7	nsv832985	chr15:42371482-42564966	Weak transcription Strong transcription Enhancers Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
8	nsv457121	chr15:42396282-42418085	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	Chromatin interactive region	n/a	inside rSNPs	diseases
9	nsv569236	chr15:42396282-42418085	Active TSS Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	n/a	inside rSNPs	diseases

No data

Chromatin state (count:46 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:42410600-42411800	Enhancers	H9 Cell Line	embryonic stem cell
2	chr15:42410600-42411800	Enhancers	iPS-15b Cell Line	embryonic stem cell
3	chr15:42410800-42411600	Enhancers	Duodenum Smooth Muscle	Duodenum
4	chr15:42410800-42412000	Enhancers	Stomach Mucosa	stomach
5	chr15:42410800-42412000	Bivalent Enhancer	HepG2	liver
6	chr15:42410800-42416000	Enhancers	Primary monocytes fromperipheralblood	blood
7	chr15:42411000-42411600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr15:42411000-42411600	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
9	chr15:42411000-42411600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr15:42411000-42411600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
11	chr15:42411000-42411600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
12	chr15:42411000-42411600	Enhancers	Right Atrium	heart
13	chr15:42411000-42411600	Enhancers	Thymus	Thymus
14	chr15:42411000-42411800	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr15:42411000-42412000	Enhancers	HUES6 Cell Line	embryonic stem cell
16	chr15:42411000-42412000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
17	chr15:42411000-42412000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
18	chr15:42411000-42412000	Enhancers	Fetal Muscle Leg	muscle
19	chr15:42411000-42412000	Enhancers	Fetal Stomach	stomach
20	chr15:42411000-42412000	Enhancers	Lung	lung
21	chr15:42411000-42412000	Enhancers	Pancreas	Pancrea
22	chr15:42411000-42412000	Flanking Active TSS	Dnd41	blood
23	chr15:42411000-42414000	Enhancers	Fetal Intestine Small	intestine
24	chr15:42411200-42411600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
25	chr15:42411200-42411600	Weak transcription	Fetal Heart	heart
26	chr15:42411200-42411600	Active TSS	Rectal Mucosa Donor 29	rectum
27	chr15:42411200-42411600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
28	chr15:42411200-42411800	Flanking Active TSS	Fetal Thymus	thymus
29	chr15:42411200-42412000	Enhancers	Adipose Nuclei	Adipose
30	chr15:42411200-42412000	Active TSS	Rectal Smooth Muscle	rectum
31	chr15:42411200-42415800	Enhancers	Primary neutrophils fromperipheralblood	blood
32	chr15:42411400-42411600	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
33	chr15:42411400-42411600	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
34	chr15:42411400-42411600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
35	chr15:42411400-42411600	Enhancers	iPS-20b Cell Line	embryonic stem cell
36	chr15:42411400-42411600	Enhancers	Primary hematopoietic stem cells short term culture	blood
37	chr15:42411400-42411600	Enhancers	Brain Cingulate Gyrus	brain
38	chr15:42411400-42411600	Flanking Active TSS	Duodenum Mucosa	Duodenum
39	chr15:42411400-42411600	Flanking Active TSS	Esophagus	oesophagus
40	chr15:42411400-42411600	Flanking Active TSS	Fetal Intestine Large	intestine
41	chr15:42411400-42411600	Bivalent Enhancer	HSMMtube	muscle
42	chr15:42411400-42411600	Flanking Active TSS	NHEK	skin
43	chr15:42411400-42411800	Active TSS	Skeletal Muscle Male	skeletal muscle
44	chr15:42411400-42412000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr15:42411400-42412000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr15:42411400-42412000	Flanking Active TSS	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links